A. Heppeler

3.1k total citations · 1 hit paper
13 papers, 2.4k citations indexed

About

A. Heppeler is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, A. Heppeler has authored 13 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Neurology. Recurrent topics in A. Heppeler's work include Neuroendocrine Tumor Research Advances (10 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Neuroblastoma Research and Treatments (5 papers). A. Heppeler is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Neuroblastoma Research and Treatments (5 papers). A. Heppeler collaborates with scholars based in Switzerland, Germany and United Kingdom. A. Heppeler's co-authors include Helmut R. Mäcke, Helmut R. Maëcke, Jörg Schmitt, Jean Claude Reubi, Sandra Wenger, Beatrice Waser, Sylvie Froidevaux, Martin Béhé, Alex N. Eberlé and E. Jermann and has published in prestigious journals such as Journal of the American Chemical Society, Endocrinology and Chemistry - A European Journal.

In The Last Decade

A. Heppeler

13 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

2000 849 citations Jean Claude Reubi, Beatrice Waser et al. European Journal of Nuclear Medicine and Molecular Imaging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Heppeler Switzerland	11	1.6k	1.3k	1.2k	897	232	13	2.4k
Marco Chinol Italy	32	1.5k 0.9×	1.5k 1.1×	1.7k 1.4×	995 1.1×	383 1.7×	95	3.5k
Elisabeth von Guggenberg Austria	29	1.4k 0.9×	1.5k 1.1×	1.5k 1.2×	718 0.8×	747 3.2×	76	3.0k
Mihaela Ginj Switzerland	14	1.1k 0.7×	931 0.7×	837 0.7×	509 0.6×	176 0.8×	21	1.7k
Tina Binderup Denmark	26	962 0.6×	1.0k 0.8×	599 0.5×	710 0.8×	270 1.2×	61	2.4k
Melpomeni Fani Switzerland	34	1.8k 1.1×	2.1k 1.6×	2.1k 1.8×	812 0.9×	532 2.3×	92	3.8k
Jean‐Claude Schaer Switzerland	21	1.6k 1.0×	1.3k 1.0×	716 0.6×	708 0.8×	226 1.0×	39	2.7k
Mahila Ferrari Italy	30	1.2k 0.7×	1.2k 0.9×	1.8k 1.4×	703 0.8×	663 2.9×	87	3.1k
Jörg Schmitt Switzerland	8	1.0k 0.6×	807 0.6×	623 0.5×	541 0.6×	99 0.4×	10	1.4k
Jaap J.M. Teunissen Netherlands	30	3.2k 2.0×	2.8k 2.1×	1.2k 1.0×	2.3k 2.6×	360 1.6×	48	4.1k
Matthias Miederer Germany	25	516 0.3×	780 0.6×	1.4k 1.2×	446 0.5×	705 3.0×	84	2.4k

Countries citing papers authored by A. Heppeler

Since Specialization

Citations

This map shows the geographic impact of A. Heppeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Heppeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Heppeler more than expected).

Fields of papers citing papers by A. Heppeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Heppeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Heppeler. The network helps show where A. Heppeler may publish in the future.

Co-authorship network of co-authors of A. Heppeler

This figure shows the co-authorship network connecting the top 25 collaborators of A. Heppeler. A scholar is included among the top collaborators of A. Heppeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Heppeler. A. Heppeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Heppeler, A., João Paulo André, Xuejuan Wang, et al.. (2008). Metal‐Ion‐Dependent Biological Properties of a Chelator‐Derived Somatostatin Analogue for Tumour Targeting. Chemistry - A European Journal. 14(10). 3026–3034. 61 indexed citations

Froidevaux, Sylvie, Alex N. Eberlé, Martine Christe, et al.. (2002). Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model. International Journal of Cancer. 98(6). 930–937. 80 indexed citations

Hofmann, Michael, Helmut R. Maëcke, A. Börner, et al.. (2001). Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. European Journal of Nuclear Medicine and Molecular Imaging. 28(12). 1751–1757. 407 indexed citations

Heppeler, A., Sylvie Froidevaux, Alex N. Eberlé, & Helmut R. Maëcke. (2000). Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides. Current Medicinal Chemistry. 7(9). 971–994. 212 indexed citations

Reubi, Jean Claude, Beatrice Waser, Sandra Wenger, et al.. (2000). Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. European Journal of Nuclear Medicine and Molecular Imaging. 27(3). 273–282. 849 indexed citations breakdown →

Froidevaux, Sylvie, A. Heppeler, Alex N. Eberlé, et al.. (2000). Preclinical Comparison in AR4–2J Tumor-Bearing Mice of Four Radiolabeled 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Somatostatin Analogs for Tumor Diagnosis and Internal Radiotherapy*. Endocrinology. 141(9). 3304–3312. 52 indexed citations

Froidevaux, Sylvie, Martine Christe, Lazar T. Sumanovski, et al.. (2000). Tumor targeting with DOTA-somatosatin analogs: Superiority of GA-labeled peptides. Regulatory Peptides. 94(1-3). 76–76. 1 indexed citations

Heppeler, A., Sylvie Froidevaux, Helmut R. Mäcke, et al.. (1999). Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy. Chemistry - A European Journal. 5(7). 1974–1981. 287 indexed citations

Heppeler, A., Helmut R. Mäcke, E. Jermann, et al.. (1999). Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy. Chemistry - A European Journal. 5(7). 1974–1981. 9 indexed citations

10.

Otte, Andreas, et al.. (1999). Yttrium-90 DOTATOC: first clinical results. European Journal of Nuclear Medicine and Molecular Imaging. 26(11). 1439–1447. 269 indexed citations

11.

Otte, Andreas, E. Jermann, Martin Béhé, et al.. (1997). DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 24(7). 792–795. 171 indexed citations

12.

Blake, Alexander J., Ian A. Fallis, A. Heppeler, et al.. (1996). Synthesis, structure and characterisation of amido derivatives of [9]aneN₃(1,4,7-triazacyclononane). Journal of the Chemical Society Dalton Transactions. 31–43. 11 indexed citations

13.

Alberts, Ian L., R. E. BANKS, Alexander J. Blake, et al.. (1996). Perfluorocyclopropene: Experimental and Theoretical Studies of Its Structure in Gaseous, Solution, and Crystalline Phases. Journal of the American Chemical Society. 118(1). 209–216. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact